- Home
- Mathematics
- Probability & Statistics
- Biosimilar Clinical Development: Scientific Considerations and New Methodologies
Biosimilar Clinical Development: Scientific Considerations and New Methodologies
List Price:
$68.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Kerry B. Barker, Sandeep M. Menon, Ralph B. D'Agostino, Sr., Siyan Xu, Bo Jin, PhD
Format:
Paperback
Pages:
268
Publisher:
CRC Press (December 18, 2020)
Language:
English
ISBN-13:
9780367736521
Weight:
17.75oz
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260206052836509-20260206.xml
Folder:
TAYLORFRANCIS
List Price:
$68.99
Series:
Chapman & Hall/CRC Biostatistics Series
Case Pack:
10
As low as:
$65.54
Publisher Identifier:
P-CRC
Discount Code:
H
Country of Origin:
United States
Pub Discount:
30
Imprint:
Chapman and Hall/CRC
Overview
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
